The Pathology Committee of The Global Society of Rare Genitourinary Tumors @Gtumors is dedicated to fighting diagnostic & therapeutic disparities of rare GU tumors by promoting global education & research collaborations.
#GUPATH
We will be discussing:
1. Key surgical principles and concepts of nephroureterectomy
2. The role of post-operative administration of intravesical therapy
3. The role of adjuvant systemic therapy in patients with adverse pathological features
Can we stage better patients with #prostatecancer#metastatic to the lymph nodes?
📢 It is time to try! Check out our study below ⬇️
#GUPATH#Pathology#PathTwitter
Risk Stratification of Prostatic Adenocarcinoma Metastatic to the Lymph Nodes https://t.co/1DdWHbyEhD
COLABORACIÓN ACADÉMICA ENTRE GSRGT Y LA CAU
El GSRGT ha elaborado este cuestionario con el objetivo de recopilar información sobre los patrones de práctica entre los expertos de todo el mundo que se ocupan del cáncer de pene.
Enlace en español:https://t.co/Z39hJFXVNF
@GSRGTPath
Thank u @h_alahmadie and @henning_reis 4 organizing the outstanding webinar: Urinary Tract Diagnostic Challenges and Therapeutic Update
Thanks to the expert speakers without whom this could not happen
✅ https://t.co/Zh58YzwvJU for recording (coming soon)
#GUPATH#PathTwitter
Join us on Saturday October 30th from 8a-12:30p EST USA
Urinary Tract: Diagnostic Challenges and Therapeutic updates
Free registration and program details @
https://t.co/heQjnGaWNA
#pathology#pathtwitter#pathres#GUPATH
📢 Join us this Saturday October 30th from 8a-12:30p EST USA 📢
💮 Urinary Tract: Diagnostic Challenges and Therapeutic updates 💮
Free registration and program details @
https://t.co/Qa7BNpzqs8
#pathology#pathtwitter#pathres#GUPATH
Less than 2 weeks away!
Join us to learn more about Diagnostic Challenges and Therapeutic Updates of the Urinary Tract
Register soon @
https://t.co/kZwiuaduXK
#PathTwitter#pathology#GUPATH
📢 Join us on Saturday October 30th from 8a-12:30p EST USA 📢
💮Urinary Tract: Diagnostic Challenges and Therapeutic updates💮
Free registration and program details @
https://t.co/kZwiuaduXK
#pathology#pathtwitter#pathres#GUPATH
@SpiessPhilippe@GTumors@AndreaNecchi Interesting findings Phil..Some recent revisits on primary at predicting pN+ and now this at nodal behaviour.. surprisingly LVI was turning out the strongest but looks different here .. thoughts from a recent talk.. @GSRGTPath @Santosh34632205 @dramandeeparora